Report : North America Protein Expression Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Competent Cells, Expression Vectors, Reagents, and Instruments); Services (Antibody Development & Production, Protein Expression & Production, Hybridoma One-Stop Services, Stable Cell Line Development, and Bioanalytical Assay Services); Application (Research, Therapeutic, and Industrial); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Others)
Reagents Segment has the Largest Share of Product in the North America Protein Expression Market during 2021–2028
According to a new market research study on “North America Protein Expression Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Services, Application, and End User” is expected to reach US$ 1,595.9 million by 2028 from US$ 872.9 million in 2021. The market is estimated to grow at a CAGR of 9.0% from 2021 to 2028. The report provides trends prevailing in the North America Protein expression market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing applications of protein expression and the growing adoption of precision medicines are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the high cost of products.
As the current pandemic is demonstrating across the region, the pharma industry can respond robustly to the health crisis but at a cost that society may not be able to sustain under current bioprocessing development and manufacturing models. Centuries of detecting, responding, and treating pandemics have taught that if a virus (or any biologic threat) is extremely infectious and transmittable, it can spread quickly and propagate in vast numbers of people, quickly jumping social distance, borders and the ability of healthcare systems to treat the sick. The way vaccines are developed and rolled out today is about the same as it has been for the past several decades. Currently, the region mainly relies on Chinese Hamster Ovary (CHO) cells or insect cells for expression as the gold standard, but its expense and processing complexity is driving developers to consider emerging cell line (hosts in which to express these proteins and vaccines) alternatives. To help combat the Covid-19 outbreak Dyadic International, Inc. developed a hyper productive C1 cell line that produces a SARS-CoV-2 Receptor Binding Domain (RBD) antigen from the Dyadic C1 gene expression platform that expresses the RBD antigen at three grams per liter (3.5 g/l) in only four days. The impact of the COVID19 pandemic on the regional protein expression market is high.
The market for protein expression market is segmented into product, services, application, and end user. Based on product, the protein expression market is segmented into instruments, expression vectors, reagents, and competent cells. In 2020, the reagents segment is estimated to account for the largest market share in the protein expression market. The high incidence of chronic diseases and the increasing public and private investments account for dominance of this segment.
Thermo Fisher Scientific Inc., GenScript, Merck KGaA, Agilent Technologies, Inc., Takara Bio Inc., Bio-Rad Laboratories Inc., QIAGEN, New England Biolabs, and Promega Corporation are among the leading companies in the North America protein expression market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, Thermo Fisher Scientific to Acquired QIAGEN N.V. Benefits of the Transaction are Expands Specialty Diagnostics Portfolio with Attractive Molecular Diagnostics Capabilities, Including Infectious Disease Testing, Complementary Offering Enhances Unique Value Proposition for Life Sciences Customers, Commercial and Geographic Reach Expand Customer Access, Delivers Attractive Financial Benefits through the PPI Business System, Including Proven Integration Approach.
The market for protein expression market is segmented into product, services, application, and end user. Based on product, the protein expression market is segmented into competent cells, expression vectors, reagents, and instruments. Based on services, the protein expression market is segmented into antibody development & production, protein expression & production, hybridoma one-stop services, stable cell line development, and bioanalytical assay services. Based on application, the protein expression market is segmented into research, therapeutic, and industrial. Based on end user, the protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and others. Geographically, the protein expression market is segmented into North America (US, Canada, Mexico).